Bright Minds Biosciences Inc (DRUG)

Precedente Chiudi:

$1.085

Aprire:

$1.1

Volume 24 ore:

13,559

Capitalizzazione di mercato:

$4.73M

Reddito:

-

Utile/perdita netta:

$-4.98M

Rapporto P/E:

-0.5462

EPS:

-1.9408

Flusso di cassa netto:

$-3.85M

1 W Prestazione:

-4.07%

1M Prestazione:

-7.02%

6M Prestazione:

-13.82%

1 anno Prestazione:

+87.91%

Intervallo 1D:

$1.02

$1.11

Portata 52W:

$0.4791

$6.44

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Nome

Bright Minds Biosciences Inc

Settore

Healthcare (1211)

Industria

Biotechnology (697)

Telefono

647 407 2515

Indirizzo

19 Vestry Street, New York

Dipendente

0

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

DRUG's Discussions on Twitter

Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie

Mind Medicine sends psychedelic stocks higher on LSD drug - Seeking Alpha

Seeking Alpha

Bright Minds trims losses, but deficit grows - Green Market Report

Green Market Report

Short sales on the TSX: What bearish investors are betting against - The Globe and Mail

The Globe and Mail

Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More - Benzinga

Benzinga

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More - Com - Benzinga

Benzinga

PurMinds Appoints Leading Drug Designer to Scientific Advisory Board - Microdose Psychedelic Insights

Microdose Psychedelic Insights

Bright Minds Biosciences Inc Azioni (DRUG) Dati Finanziari

Bright Minds Biosciences Inc (DRUG) Reddito netto 2024

Bright Minds Biosciences Inc (DRUG) Flusso di cassa 2024

Bright Minds Biosciences Inc (DRUG) Utile per azione 2024